Yao Zhang, MD, MPHAssociate Director, Research
Areas of expertise
- Adult internal medicine
- Clinical research
- Clinical trials
- Quantitative analysis
Projects & Resources
FHI 360’s China Tuberculosis Clinical Trials Consortium provides mentoring and advice on the critical aspects of maintaining a successful tuberculosis clinical trial network in China.
Regional Prospective Observational Research in Tuberculosis (RePORT) International Coordinating Center
FHI 360 leads the Regional Prospective Observational Research in Tuberculosis (RePORT) International Coordinating Center (RICC), which manages worldwide research teams.
Published Research/** * @file * Unformatted override for published research. * Using the same markup as "project" because it's the same */ ?>
Adjuvant corticosteroid treatment in adults with influenza A (H7N9) viral pneumonia
Cao B, Gao H, Zhou B, Deng X, Hu C, Deng C, Lu H, Li Y, Gan J, Liu J, Li H, Zhang Y, Yang Y, Fang Q, Shen Y, Gu Q, Zhou X, Zhao W, Pu Z, Chen L, Sun B, Liu X, Hamilton CD, Li L
Crit Care Med 2016 Jun; 44 (6): e318-28. [Journal Impact Factor: 6.312]
This retrospective study of 288 adults and adolescents determined the impact of adjuvant corticosteroids administered to patients hospitalized with severe influenza A (H7N9) viral pneumonia in mainland China. The authors found that, contrary to expectations, high-dose corticosteroids were associated with increased mortality and longer viral shedding in patients with influenza A (H7N9) viral pneumonia. The authors conclude that corticosteroids are not indicated for use with this type of severe influenza.